The markets closed higher with the Dow climbing 69 points to 22,830 after Catalan President Carles Puigdemont suspended its declaration of independence from Spain. Nasdaq rose 7 points to 6,587.
On the upside
AnaptysBio (Nasdaq: ANAB) reported positive proof-of-concept data from an ongoing Phase 2a clinical trial of ANB020 to treat moderate to severe atopic dermatitis.
KalVista Pharmaceuticals (Nasdaq: KALV) entered a collaboration agreement with Merck (NYSE: MRK).
H.C. Wainwright analyst Oren Livnat initiated coverage of MannKind (Nasdaq: MNKD) with a Buy rating and a $7.00 price target.
On the downside
Scotiabank reiterated its Hold rating on Apache (NYSE: APA).
Shares of Catabasis Pharmaceuticals (Nasdaq: CATB) continued to fall.
New Jersey Attorney General Christopher S. Perrino filed a suit against Insys Therapeutics (Nasdaq: INSY) alleging that the specialty pharmaceutical engaged in aggressive marketing tactics including off label uses of its opioid fentanyl drug Subsys.
In the broad market, advancing issues outpaced decliners by a margin of more than 9 to 5 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 rose 5 points to 2,550. Bitcoin surged $63 to $4,866.